Tango Therapeutics, Inc. - TNGX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | TCG Crossover GP II, LLC | 8.1% | 11,597,737 | View |
| May 15, 2026 | SCHEDULE 13G/A | TCG Crossover Fund II, L.P. | 8.1% | 11,597,737 | View |
| May 15, 2026 | SCHEDULE 13G/A | Chen Yu | 8.1% | 11,597,737 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nextech Crossover I GP S.a. r.l. | 5.1% | 7,266,081 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nextech Crossover I SCSp | 5.1% | 7,266,081 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ian Charoub | 5.1% | 7,266,081 | View |
| May 15, 2026 | SCHEDULE 13G/A | Costas Constantinides | 5.1% | 7,266,081 | View |
| May 15, 2026 | SCHEDULE 13G/A | Rocco Sgobbo | 5.1% | 7,266,081 | View |
| May 15, 2026 | SCHEDULE 13G | RTW Investments, LP | 9.3% | 13,300,620 | View |
| May 15, 2026 | SCHEDULE 13G | Roderick Wong | 9.3% | 13,300,620 | View |
| May 15, 2026 | SCHEDULE 13G/A | Woodline Partners LP | 5.6% | 8,000,013 | View |
| May 13, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 8.98% | 12,809,485 | View |
| May 13, 2026 | SCHEDULE 13G/A | Robert Atchinson | 8.98% | 12,809,485 | View |
| May 13, 2026 | SCHEDULE 13G/A | Phillip Gross | 8.98% | 12,809,485 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 0.7% | 1,055,717 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 1.0% | 1,470,591 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.2% | 290,563 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.2% | 226,033 | View |
| May 11, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.2% | 260,503 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 1.7% | 2,488,434 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.1% | 163,734 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.2% | 292,726 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners Master, L.P. | 3.5% | 5,008,902 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 7.6% | 10,964,477 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.2% | 260,503 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.2% | 292,726 | View |
| May 11, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners (GP), L.L.C. | 3.5% | 5,008,902 | View |
| May 11, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Kim, David T. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Saito Edric C. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Short Daniel S. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Warren, John R. | 7.8% | 11,257,203 | View |
| May 11, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 7.8% | 11,257,203 | View |
| May 06, 2026 | SCHEDULE 13G | FMR LLC | 6.9% | 9,905,919 | View |
| May 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 6.9% | 9,905,919 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 3.5% | 4,964,650 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 3.5% | 4,964,650 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 3.5% | 4,964,650 | View |
| May 04, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 3.5% | 4,964,650 | View |
| May 04, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 0.5% | 692,455 | View |
| May 04, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 0.5% | 692,455 | View |
| May 04, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 0.5% | 692,455 | View |
| May 04, 2026 | SCHEDULE 13G/A | Raymond Debbane | 4.0% | 5,657,105 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | EcoR1 Capital, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Oleg Nodelman | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | EcoR1 Capital Fund Qualified, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Woodline Partners LP | 7.5% | 10,072,225 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TCG Crossover GP II, L.P. | 9.99% | 13,521,839 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TCG Crossover Fund II, L.P. | 9.99% | 13,521,839 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Chen Yu | 9.99% | 13,521,839 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 5.3% | 7,068,444 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 5.3% | 7,068,444 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 5.3% | 7,068,444 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 5.3% | 7,068,444 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 0.8% | 1,096,930 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 0.8% | 1,096,930 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 0.8% | 1,096,930 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Raymond Debbane | 6.1% | 8,165,374 | View |
| Feb 12, 2026 | SCHEDULE 13G | Adage Capital Management, L.P. | 7.88% | 10,607,924 | View |
| Feb 12, 2026 | SCHEDULE 13G | Robert Atchinson | 7.88% | 10,607,924 | View |
| Feb 12, 2026 | SCHEDULE 13G | Phillip Gross | 7.88% | 10,607,924 | View |
| Feb 10, 2026 | SCHEDULE 13D/A | — | 1.0% | — | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital Partners, L.P. | 1.6% | 2,199,950 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners, L.P. | 2.2% | 2,922,242 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners II, L.P. | 0.5% | 710,502 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital Institutional Partners III, L.P. | 0.4% | 496,032 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Four Crossings Institutional Partners V, L.P. | 0.4% | 605,612 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital Offshore Investors II, L.P. | 3.9% | 5,280,943 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital (AM) Investors, L.P. | 0.3% | 359,837 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Capital F5 Master I, L.P. | 0.4% | 556,097 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners Master, L.P. | 0.2% | 330,000 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Partners, L.L.C. | 9.6% | 12,905,118 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Institutional (GP) V, L.L.C. | 0.4% | 605,612 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon F5 (GP), L.L.C. | 0.4% | 556,097 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Farallon Healthcare Partners (GP), L.L.C. | 0.2% | 330,000 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Dapice Joshua J. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Dreyfuss, Philip D. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Dunn Hannah E. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Fried, Richard B | 0.0% | 0 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Gehani, Varun N. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Giauque, Nicolas | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Husen, Avner A. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Kim, David T. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Linn, Michael G. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Luo Patrick (Cheng) | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Patel, Rajiv A. | 0.0% | 0 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Roberts, Jr., Thomas G. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Saito Edric C. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Seybold, William | 0.0% | 0 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Short Daniel S. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Spokes, Andrew J. M. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Warren, John R. | 9.99% | 13,461,215 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Wehrly, Mark C. | 9.99% | 13,461,215 | View |
| Jan 30, 2026 | SCHEDULE 13G | The Vanguard Group | 5.01% | 6,750,977 | View |
| Jan 21, 2026 | SCHEDULE 13G | BlackRock, Inc. | 6.3% | 8,477,165 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.